Gallbladder amyloidosis is often unexpected and may have systemic implications
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf090 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Catherine E Hagen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Amyloidosis, Gallbladder Diseases, Gallbladder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester.
Abstract (Originalsprache)
Objective
The aim of this study was to evaluate a large cohort of gallbladder amyloid cases to determine clinical and morphologic features.
Methods
Cholecystectomy specimens (N = 118) typed using proteomics-based techniques between 2008 and 2023 were identified. Clinical and morphologic features were reviewed.
Results
Six amyloid types were identified: ATTR (n = 63, 53.4%), AL (n = 46, 39.0%), AA (n = 4, 3.4%), AApoA1 (n = 2, 1.7%), ALECT2 (n = 2, 1.7%), and AEFEMP1 (n = 1, 0.8%). Amyloidogenic mutations were detected in 3 ATTR cases and 2 AApoA1 cases. Morphologic review (n = 26) revealed perimuscular vessel involvement in all cases. Amyloidosis was an unexpected diagnosis first made on the cholecystectomy specimen in half of the patients with clinical information (n = 10). All 9 patients with follow-up had evidence of systemic disease. In 2 patients, cholecystic involvement was initially missed and only retrospectively identified after the diagnosis of cardiac amyloidosis.
Conclusions
In patients with clinical data, amyloidosis was often unexpected, the gallbladder was commonly the first tissue sampled with amyloidosis, and all patients had systemic disease. Thorough review of cholecystectomy specimens with careful inspection of perimuscular vessels, coupled with a low threshold for ordering Congo red stain in elderly individuals and amyloid typing using a robust method such as proteomics, can prevent a delay in amyloid diagnosis and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
- Department of Medicine, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: Catherine E Hagen, Joanna Dalland
Förderung
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
Zitieren
APA
Hagen, C. E., Dasari, S., Theis, J. D., Rech, K., Dao, L., Howard, M., Larson, D. P., Nasr, S. H., Dispenzieri, A., Chiu, A., Dalland, J., Gertz, M., Kourelis, T., Muchtar, E., Vrana, J. A., & McPhail, E. D. (2025). Gallbladder amyloidosis is often unexpected and may have systemic implications. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf090
Vancouver
Hagen CE, Dasari S, Theis JD, Rech K, Dao L, Howard M, et al. Gallbladder amyloidosis is often unexpected and may have systemic implications. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf090
BibTeX
@article{Hagen2025,
author = {Hagen, Catherine E and Dasari, Surendra and Theis, Jason D and Rech, Karen and Dao, Linda and Howard, Matthew and Larson, Daniel P and Nasr, Samih H and Dispenzieri, Angela and Chiu, April and Dalland, Joanna and Gertz, Morie and Kourelis, Taxiarchis and Muchtar, Eli and Vrana, Julie A and McPhail, Ellen D},
title = {Gallbladder amyloidosis is often unexpected and may have systemic implications},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf090}
}
EUVIMED